O
Omniscient Neurotechnology
Biotech & Life Sciences · Sydney, Australia · Founded 2019
Enterprise grade clinical and research solutions applicable to a variety of brain-related disorders MoreLess
O8t.com, also known as Omniscient, operates in the healthcare technology sector, specifically focusing on neurology and brain health. The company's primary offering is a digital brain mapping solution, known as the connectome, which uses artificial intelligence (AI) and cloud computing to process vast quantities of neural data. This technology provides precise knowledge of a patient's unique brain networks, offering actionable insights for surgeons prior to life-changing surgeries.
The company's solutions are designed for a wide range of clients, including neurosurgeons, psychologists, and researchers. By providing a more robust understanding of the brain, Omniscient's tools aim to enhance the diagnosis and treatment of neurological conditions, thereby improving patient outcomes.
Omniscient's business model revolves around the development and sale of its brain mapping technology. The company generates revenue by partnering with healthcare institutions and professionals who utilize their technology for surgical planning and research purposes.
In addition to its commercial activities, Omniscient is also heavily involved in research and development. The company collaborates with top institutions worldwide to push the boundaries of brain health understanding and technology.
Keywords: Healthcare Technology, Neurology, Brain Mapping, Artificial Intelligence, Cloud Computing, Neurosurgery, Psychology, Research, Diagnosis, Treatment.
Company overview
Omniscient Neurotechnology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2019
- Headquarters
- Sydney, Australia
- Employees
- 65
- Open positions
- 11
- Dealroom signal
- 80.3
Valuation & funding
Omniscient Neurotechnology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | May 2026 | $27M | $445M | Gina Rinehart · Will Vicars · Australian National Reconstruction Fund | ↗ |
| SERIES COther financing | Jun 2024 | $58M | $230M | Will Vicars · Gina Rinehart | ↗ |
| SERIES BOther financing | Jul 2021 | $26M | $259M | Gina Rinehart · Gretel Packer · Kerr Neilson · Will Vicars | ↗ |
| SERIES AOther financing | Jan 2020 | $13M | $52M | Undisclosed | — |
Growth signals
Omniscient Neurotechnology website traffic
Latest recorded traffic for Omniscient Neurotechnology is 32K monthly website visits, up 28% over the last three months. Omniscient Neurotechnology's team grew 12.1% over the past year.
Hiring
Open positions at Omniscient Neurotechnology
Current openings linked to this company in Dealroom.
Comparisons
Omniscient Neurotechnology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Omniscient Neurotechnology's talent
Source: Dealroom Talent Intelligence.
Investors
5 investors on Omniscient Neurotechnology's cap table
Sourced from Dealroom's funding and investor records.

Global footprint
Where Omniscient Neurotechnology has talent and traffic
team presence
In the news
Latest news about Omniscient Neurotechnology
Recent press, funding announcements, and product moves mentioning Omniscient Neurotechnology — open to read from the original sources.
Market sentiment
What the market is saying about Omniscient Neurotechnology
An AI-synthesized read of the highest-engagement posts about Omniscient Neurotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Omniscient Neurotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







